BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19021060)

  • 1. Polymorphisms of tumor-necrosis factor-alpha - 308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells.
    Jevtovic-Stoimenov T; Kocic G; Pavlovic D; Macukanovic-Golubovic L; Marjanovic G; Djordjevic V; Tosić N; Pavlović S
    Leuk Lymphoma; 2008 Nov; 49(11):2163-9. PubMed ID: 19021060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt.
    Ibrahim A; Abdel Rahman H; Khorshied M; Sami R; Nasr N; Khorshid O
    Leuk Res; 2012 Jun; 36(6):694-8. PubMed ID: 22177457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
    Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
    J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between non-Hodgkin lymphoma and haplotypes in the TNF region.
    Spink CF; Keen LJ; Mensah FK; Law GR; Bidwell JL; Morgan GJ
    Br J Haematol; 2006 May; 133(3):293-300. PubMed ID: 16643431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia.
    Demeter J; Porzsolt F; Rämisch S; Schmidt D; Schmid M; Messer G
    Br J Haematol; 1997 Apr; 97(1):107-12. PubMed ID: 9136948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
    Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
    Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the +252(A/G) lymphotoxin-alpha and the -308(A/G) tumor necrosis factor-alpha genes and susceptibility to chronic periodontitis in a Czech population.
    Fassmann A; Holla LI; Buckova D; Vasku A; Znojil V; Vanek J
    J Periodontal Res; 2003 Aug; 38(4):394-9. PubMed ID: 12828656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
    Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis.
    Pantelidis P; Fanning GC; Wells AU; Welsh KI; Du Bois RM
    Am J Respir Crit Care Med; 2001 May; 163(6):1432-6. PubMed ID: 11371414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.
    Cao C; Liu S; Lou SF; Liu T
    Eur Rev Med Pharmacol Sci; 2014; 18(4):544-52. PubMed ID: 24610621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-α and LT-α polymorphisms and the risk of leukemia: a meta-analysis.
    Gong LL; Han FF; Lv YL; Liu H; Wan ZR; Zhang W; Shi MB; Pei LX; Liu LH
    Tumori; 2017 Jan; 103(1):53-59. PubMed ID: 27647233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor/cachectin and lymphotoxin gene expression in lymph nodes from lymphoma patients.
    Sappino AP; Seelentag W; Pelte MF; Alberto P; Vassalli P
    Blood; 1990 Feb; 75(4):958-62. PubMed ID: 2302463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between tumor necrosis factor-alpha and lymphotoxin-alpha polymorphisms and idiopathic recurrent miscarriage.
    Zammiti W; Mtiraoui N; Khairi H; Gris JC; Almawi WY; Mahjoub T
    Reproduction; 2008 Mar; 135(3):397-403. PubMed ID: 18299433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphotoxin-alpha is an autocrine growth factor for chronic lymphocytic leukemia B cells.
    Kulmburg P; Radke M; Digel W
    Leukemia; 1998 Apr; 12(4):493-8. PubMed ID: 9557606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Tumor Necrosis Factor Alpha and Lymphotoxin Alpha Gene Polymorphisms with the Presence of Chronic Obstructive Pulmonary Disease.
    Tarigan AP; Syafiuddin T; Yunus F; Suradi
    Acta Med Indones; 2015 Oct; 47(4):283-90. PubMed ID: 26932696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas].
    Kalinka E; Juszczyński P; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffier B; Salles G; Warzocha K
    Przegl Lek; 2005; 62(12):1422-6. PubMed ID: 16786764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production.
    Grimble RF; Howell WM; O'Reilly G; Turner SJ; Markovic O; Hirrell S; East JM; Calder PC
    Am J Clin Nutr; 2002 Aug; 76(2):454-9. PubMed ID: 12145022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.
    Aissani B; Ogwaro KM; Shrestha S; Tang J; Breen EC; Wong HL; Jacobson LP; Rabkin CS; Ambinder RF; Martinez-Maza O; Kaslow RA
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):170-9. PubMed ID: 19654554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.